Clinical Trials Directory

Trials / Completed

CompletedNCT06702202

Effect of Subarachnoid Block and Femoropopliteal Block to Limb Perfusion in PAD Patients

Comparison of the Effect of Subarachnoid Block and Femoropopliteal Block to Limb Perfusion in Patients with Peripheral Arterial Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Indonesia University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This pilot study investigates the effects of femoropopliteal and subarachnoid nerve blocks on tissue oxygen saturation (StO2) in patients with Peripheral Arterial Disease (PAD) during lower limb surgeries. Using Near-Infrared Spectroscopy (NIRS), the study compares changes in StO2 post-block. Although no significant differences were found between the two block types at most time points, subarachnoid blocks generally led to higher StO2 increases compared to femoropopliteal blocks, with significant differences observed at 5 and 15 minutes post-block.

Detailed description

This pilot study explored the impact of femoropopliteal and subarachnoid nerve blocks on tissue oxygen saturation (StO2) in patients with Peripheral Arterial Disease (PAD) during lower limb surgeries, using Near-Infrared Spectroscopy (NIRS) for non-invasive monitoring. The study compared StO2 changes at baseline, 5, 15, and 30 minutes post-block in two groups: those receiving femoropopliteal blocks and those receiving subarachnoid blocks.

Conditions

Interventions

TypeNameDescription
DRUGMixture of local anestheticsMarcaine® (bupivacaine HCl) 0,5% and Xylocaine® (Lidocaine HCL) 2% = 2:1 Given in Femoropopliteal block group (Group F)
DRUG0.5% hyperbaric bupivacaineGiven in Subarachnoid block group (Group S)

Timeline

Start date
2024-01-01
Primary completion
2024-07-01
Completion
2024-07-01
First posted
2024-11-22
Last updated
2024-11-22

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT06702202. Inclusion in this directory is not an endorsement.